Literature DB >> 16646584

Life cycle of connexins: regulation of connexin synthesis and degradation.

Aida Salameh1.   

Abstract

Gap-junction-forming connexins (Cx) exhibit a complex life cycle which is regulated at various levels. First, the promoter regions and binding of transcription factors to them control the transcription of the connexin genes. Translation of Cx-mRNA seems to be enabled by internal ribosome entry site elements allowing translation even under stress conditions. The newly synthetized Cx protein (monomeric) is transferred to the Golgi apparatus, oligomerized, transferred to the plasma membrane and incorporated into gap junction plaques. Two principal pathways for degradation of Cx could be defined: (a) lysosomal and (b) proteasomal degradation, including phosphorylation and ubiquitination as well as the internalization of complete gap junction channels as annular gap junctions doomed to degradation. In the present article, the various steps of the life cycle of cardiac connexins and its regulation are reviewed.

Mesh:

Substances:

Year:  2006        PMID: 16646584     DOI: 10.1159/000092562

Source DB:  PubMed          Journal:  Adv Cardiol        ISSN: 0065-2326


  17 in total

Review 1.  Degradation of connexins through the proteasomal, endolysosomal and phagolysosomal pathways.

Authors:  Vivian Su; Kimberly Cochrane; Alan F Lau
Journal:  J Membr Biol       Date:  2012-07-08       Impact factor: 1.843

Review 2.  The role of connexins in prostate cancer promotion and progression.

Authors:  Jarosław Czyż; Katarzyna Szpak; Zbigniew Madeja
Journal:  Nat Rev Urol       Date:  2012-02-21       Impact factor: 14.432

3.  Investigation of the reciprocal relationship between the expression of two gap junction connexin proteins, connexin46 and connexin43.

Authors:  Debarshi Banerjee; Satyabrata Das; Samuel A Molina; Dan Madgwick; Melanie R Katz; Snehalata Jena; Leonie K Bossmann; Debjani Pal; Dolores J Takemoto
Journal:  J Biol Chem       Date:  2011-05-23       Impact factor: 5.157

Review 4.  Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications.

Authors:  Luc Leybaert; Paul D Lampe; Stefan Dhein; Brenda R Kwak; Peter Ferdinandy; Eric C Beyer; Dale W Laird; Christian C Naus; Colin R Green; Rainer Schulz
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

5.  GATA6 reporter gene reveals myocardial phenotypic heterogeneity that is related to variations in gap junction coupling.

Authors:  Mathieu C Rémond; Grazia Iaffaldano; Michael P O'Quinn; Nadejda V Mezentseva; Victor Garcia; Brett S Harris; Robert G Gourdie; Carol A Eisenberg; Leonard M Eisenberg
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-09-09       Impact factor: 4.733

6.  Connexin45 expression in the human obstructed detrusor muscle.

Authors:  Hubert John; Michael Walch; Theresa Lehmann; Caroline Maake
Journal:  World J Urol       Date:  2009-01-15       Impact factor: 4.226

7.  The role of the C-terminus in functional expression and internalization of rat connexin46 (rCx46).

Authors:  Barbara Schlingmann; Patrik Schadzek; Franziska Hemmerling; Frank Schaarschmidt; Alexander Heisterkamp; Anaclet Ngezahayo
Journal:  J Bioenerg Biomembr       Date:  2012-10-14       Impact factor: 2.945

8.  Cellular signaling crosstalk between Wnt signaling and gap junctions inbenzo[a]pyrene toxicity.

Authors:  Dong-Hoon Won; Da-Bin Hwang; Yoo-Sub Shin; Shin-Young Kim; Changuk Kim; In-Sun Hong; Byeong-Cheol Kang; Jeong-Hwan Che; Jun-Won Yun
Journal:  Cell Biol Toxicol       Date:  2021-07-20       Impact factor: 6.691

9.  Temporal changes in expression of connexin 43 after load-induced hypertrophy in vitro.

Authors:  Tepmanas Bupha-Intr; Kaylan M Haizlip; Paul M L Janssen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-01-09       Impact factor: 4.733

10.  The effect of the PQ1 anti-breast cancer agent on normal tissues.

Authors:  Ying Ding; Keshar Prasain; Thi D T Nguyen; Duy H Hua; Thu Annelise Nguyen
Journal:  Anticancer Drugs       Date:  2012-10       Impact factor: 2.248

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.